Trial intelligence / Profile preview

Ezetimibe monotherapy in children with primary hypercholesterolemia

NCT00867165Phase 3Completed

Sponsor
Organon & Co.
Start
May 2009
Primary completion
Apr 2012
Modality
Small Molecules
01

Overview

A Phase 3 trial of ezetimibe in hypercholesterolemia, sponsored by Organon & Co.. Started May 2009; status: completed.

02

Drugs

ezetimibe
03

Conditions

hypercholesterolemia

Beyond the preview

Go deeper on NCT00867165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00867165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call